Expression of recombinant human mutant granulocyte colony stimulating factor (Nartograstim) in Escherichia coli

World Journal of Microbiology and Biotechnology

Volumn 28, Issue 7, 2012, Pages 2593-2600

  Gomes, F R ^a   Maluenda, A C ^b   Tapias J O ^b   Oliveira, F L S ^b   Sa Rocha L C ^c   Carvalho, E ^a   Ho, P L ^a  

^a INSTITUTO BUTANTAN   (Brazil)

^b CIALLYX Laboratórios and Consultoria   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Escherichia coli; Expression system; G CSF; High yields; Nartograstim; Recombinant human granulocyte colony stimulating factor

Indexed keywords

EXPRESSION SYSTEM; G-CSF; GRANULOCYTE-COLONY STIMULATING FACTOR; HIGH YIELD; NARTOGRASTIM;

AMINO ACIDS; BIOACTIVITY; RECOMBINANT PROTEINS;

ESCHERICHIA COLI;

GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT PROTEIN;

ARTICLE; ESCHERICHIA COLI; GENETICS; HUMAN; METABOLISM;

ESCHERICHIA COLI; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; RECOMBINANT PROTEINS;

ESCHERICHIA COLI; MUS;

EID: 84862322544     PISSN: 09593993     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11274-012-1068-4     Document Type: Article

References (44)

1. Barreda DR, Hanington PC, Belosevic M (2004) Regulation of myeloid development and function by colony stimulating factors. Dev Comp Immunol 28: 509-554. doi: 10. 1016/j. dci. 2003. 09. 010.
2. Bishop B, Koay D, Sartorelli A, Regan L (2001) Reengineering granulocyte colony-stimulating factor for enhanced stability. J Biol Chem 276: 33465-33470. doi: 10. 1074/jbc. M104494200.
3. Boneberg E, Hartung T (2002) Molecular aspects of anti-inflammatory action of G-CSF. Inflamm Res 51: 119-128.
4. Cebon J, Layton JE, Maher D, Morstyn G (1994) Endogenous haemopoietic growth factors in neutropenia and infection. Br J Haematol 86(2): 265-274.
5. Clark SC, Kamen R (1987) The human hematopoietic colony-stimulating factors. Science 236: 1229-1237.
6. Compton LA, Johnson WC (1986) Analysis of protein circular-dichroism spectra for secondary structure using a simple matrix multiplication. Anal Biochem 155: 155-167.
7. Devlin PE, Drummond RJ, Toy P, Mark DF, Watt KWK, Devlin JJ (1988) Alteration of amino-terminal codons of human granulocyte-colony-stimulating factor increases expression levels and allows efficient processing by methionine aminopeptidase in Escherichia coli. Gene 65: 13-22.
8. Ferreira DM, Darrieux M, Silva DA, Leite LC, Ferreira JM Jr, Ho PL, Miyaji EN, Oliveira ML (2009) Characterization of protective mucosal and systemic immune responses elicited by pneumococcal surface protein PspA and PspC nasal vaccines against a respiratory pneumococcal challenge in mice. Clin Vaccine Immunol 16: 636-645. doi: 10. 1128/CVI. 00395-08.
9. Fredrick K, Ibba M (2010) How the sequence of a gene can tune its translation. Cell 141: 227-229. doi: 10. 1016/j. cell. 2010. 03. 033.
10. Fujii I, Nagahara Y, Yamasaki M, Yokoo Y, Itoh S, Hirayama N (1997) Structure of KW-2228, a tailored human granulocyte colony-stimulating factor with enhanced biological activity and stability. FEBS Lett 410: 131-135.
11. Hill CP, Osslund TD, Eisenberg D (1993) The structure of granulocyte-colony-stimulating factor and its relationship to other growth factors. Proc Natl Acad Sci USA 90: 5167-5171.
12. Hubel K, Engert A (2003) Clinical applications of granulocyte colony-stimulating factor: an update and summary. Ann Hematol 82: 207-213. doi: 10. 1007/s00277-003-0628-y.
13. Jana S, Deb JK (2005) Strategies for efficient production of heterologous proteins in Escherichia coli. Appl Microbiol Biotechnol 67: 289-298. doi: 10. 1007/s00253-004-1814-0.
14. Jevsevar S, Gaberc-Porekar V, Fonda I, Podobnik B, Grdadolnik J, Menart V (2005) Production of nonclassical inclusion bodies from which correctly folded protein can be extracted. Biotechnol Prog 21: 632-639. doi: 10. 1021/bp0497839.
15. Kang SH, Na KH, Park JH, Park CII, Lee SY, Lee YI (1995) High level expression and simple purification of recombinant human granulocyte colony-stimulating factor in E. coli. Biotechnol Lett 17: 687-692. doi: 10. 1007/BF00130351.
16. Katsumori T, Yoshino H, Hayashi M, Takahashi K, Kashiwakura I (2009) Inductive potential of recombinant human granulocyte colony-stimulating factor to mature neutrophils from X-irradiated human peripheral blood hematopoietic progenitor cells. Biol Pharm Bull 32: 1849-1853. doi: 10. 1248/bpb. 32. 1849.
17. Kuga T, Komatsu Y, Yamasaki M, Sekine S, Miyaji H, Nishi T, Sato M, Yokoo Y, Asano M, Okabe M (1989) Mutagenesis of human granulocyte colony stimulating factor. Biochem Biophys Res Commun 159: 103-111.
18. Kuwabara T, Ishikawa Y, Kobayashi H, Kobayashi S, Sugiyama Y (1995) Renal clearance of a recombinant granulocyte colony-stimulating factor, nartograstim, in rats. Pharm Res 12: 1466-1469.
19. Kuwaraba T, Kato Y, Okumura S, Kobayashi S, Yamamoto M, Ikenaga T, Deguchi T, Hirata T (1991a) Disposition of Marograstim (KW-2228) (4): pharmacokinetic studies in monkeys. Drug Metab Pharmacokinet 6: 887-897. doi: 10. 2133/dmpk. 6. 887.
20. Kuwaraba T, Okumura S, Kobayashi S, Hirata T (1991b) Disposition of Marograstim (KW-2228) (3): pharmacokinetic studies in rats. Drug Metab Pharmacokinet 6: 875-885. doi: 10. 2133/dmpk. 6. 875.
21. Li YM, Karlin A, Loike JD, Silverstein SC (2002) A critical concentration of neutrophils is required for effective bacterial killing in suspension. Proc Natl Acad Sci USA 99: 8289-8294. doi: 10. 1073/pnas. 122244799.
22. Lu HS, Boone TC, Souza LM, Lai PH (1989) Disulfide and secondary structure of recombinant human granulocyte colony-stimulating factor. Arch Biochem Biophys 268: 81-92.
23. Makrides SC (1996) Strategies for achieving high-level expression of genes in Escherichia coli. Microbiol Rev 60: 512-538.
24. Molineux G (2011) Granulocyte colony-stimulating factors. In: Lyman GH, Dale DC (eds) Hematopoietic growth factors in oncology. Springer, New York, pp 33-53.
25. Nagahara Y, Konishi N, Yokoo Y, Hirayama N (1990) Crystallization and preliminary diffraction studies of recombinant human granulocyte-stimulating factor (KW2228). J Mol Biol 214: 25-26. doi: 10. 1016/0022-2836(90)90143-A.
26. Nagata S, Tsuchiya M, Asano S, Kaziro Y, Yamazaki T, Yamamoto O, Hirata Y, Kubota N, Oheda M, Nomura H (1986) Molecular cloning and expression of cDNA for human granulocyte colony-stimulating factor. Nature 319: 415-418. doi: 10. 1038/319415a0.
27. Nakamura Y, Gojobori T, Ikemura T (2000) Codon usage tabulated from the international DNA sequence databases: status for the year 2000. Nucleic Acids Res 28: 292. doi: 10. 1093/nar/28. 1. 292.
28. Okabe M, Asano M, Kuga T, Komatsu Y, Yamasaki M, Yokoo Y, Itoh S, Morimoto M, Oka T (1990) In vitro and in vivo hematopoietic effect of mutant human granulocyte colony-stimulating factor. Blood 75(9): 1788-1793.
29. Ramos CRR, Abreu PAE, Nascimento ALTO, Ho PL (2004) A high-copy T7 Escherichia coli expression vector for the production of recombinant proteins with a minimal N-terminal His-tagged fusion peptide. Braz J Med Biol Res 37: 1103-1109. doi: 10. 1590/S0100-879X2004000800001.
30. Rao D, Narasu M, Rao A (2008) A purification method for improving the process yield and quality of recombinant human granulocyte colony-stimulating factor expressed in Escherichia coli and its characterization. Biotechnol Appl Biochem 50: 77-87. doi: 10. 1042/BA20070130.
31. Sambrook J, Fritsch E, Maniatis T (1989) Molecular cloning. Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
32. Sica S, Rutella S, Di Mario A, Salutari P, Rumi C, Ortu la Barbera E, Etuk B, Menichella G, D'Onofrio G, Leone G (1996) rhG-CSF in healthy donors: mobilization of peripheral hemopoietic progenitors and effect on peripheral blood leukocytes. J Hematother 5: 391-397.
33. Sørensen HP, Mortensen KK (2005) Soluble expression of recombinant proteins in the cytoplasm of Escherichia coli. Microb Cell Fact 4: 1. doi: 10. 1186/1475-2859-4-1.
34. Souza LM, Boone TC, Gabrilove J, Lai PH, Zsebo KM, Murdock DC, Chazin VR, Bruszewski J, Lu H, Chen KK (1986) Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells. Science 232: 61-65.
35. Suzuki T, Tohda S, Nagata K, Imai Y, Murohashi I, Nara N (1992) Enhanced effect of mutant granulocyte-colony-stimulating factor (KW-2228) on the growth of normal and leukemic hemopoietic progenitor cells in comparison with recombinant human granulocyte-colony-stimulating factor (G-CSF). Acta Haematol 87: 181-189.
36. Tanaka H, Kaneko T (1992) Pharmacokinetics of recombinant human granulocyte colony-stimulating factor in mice. Blood 79: 536-539.
37. Tanaka H, Tokiwa T (1990) Influence of renal and hepatic failure on the pharmacokinetics of recombinant human granulocyte colony-stimulating factor (KRN8601) in the rat. Cancer Res 50: 6615-6619.
38. Tanaka H, Tanaka Y, Shinagawa K, Yamagishi Y, Ohtaki K, Asano K (1997) Three types of recombinant human granulocyte colony-stimulating factor have equivalent biological activities in monkeys. Cytokine 9: 360-369. doi: 10. 1006/cyto. 1996. 0177.
39. Vanz ALS, Renard G, Palma MS, Chies JM, Dalmora SL, Basso LA, Santos DS (2008) Human granulocyte colony stimulating factor (hG-CSF): cloning, overexpression, purification and characterization. Microb Cell Fact 7: 13. doi: 10. 1186/1475-2859-7-13.
40. Weisbart RH, Golde DW (1989) Physiology of granulocyte and macrophage colony-stimulating factors in host defense. Hematol Oncol Clin North Am 3: 401-409.
41. Welte K, Gabrilove J, Bronchud M, Platzer E, Morstyn G (1996) Filgrastim (r-metHuG-CSF): the first 10 years. Blood 88: 1907-1929.
42. Whitmore L, Wallace BA (2008) Protein secondary structure analyses from circular dichroism spectroscopy: methods and reference databases. Biopolymers 89: 392-400. doi: 10. 1002/bip. 20853.
43. Wingfield P, Benedict R, Turcatti G, Allet B, Mermod JJ, DeLamarter J, Simona MG, Rose K (1988) Characterization of recombinant-derived granulocyte-colony stimulating factor (G-CSF). Biochem J 256: 213-218.
44. Yamasaki M, Konishi N, Yamaguchi K, Itoh S, Yokoo Y (1998) Purification and characterization of recombinant human granulocyte colony-stimulating factor (rhG-CSF) derivatives: KW-2228 and other derivatives. Biosci Biotechnol Biochem 62: 1528-1534.